Rituximab to Treat Neuropathy With Anti-MAG Antibodies

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00050245
First received: December 2, 2002
Last updated: November 25, 2009
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given